Showing results (1-10 of 335) with videos related to
Sort By:
Pageof 34
Current Treatment Options in Neurology|April 20, 2016
Managing Disability in Progressive Multiple SclerosisDivyanshu Dubey, Peter Sguigna, Olaf StüveCurrent Opinion in Neurology|March 31, 2016
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosisDivyanshu Dubey, Christopher A Cano, Olaf StüveCurrent Opinion in Neurology|April 2, 2016
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosisDivyanshu Dubey, Christopher A Cano, Olaf StüveExpert Review of Neurotherapeutics|August 24, 2016
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosisTil Menge, Divyanshu Dubey, Clemens Warnke, et al.Therapeutic Advances in Neurological Disorders|May 3, 2014
Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestationsDivyanshu Dubey, Vibhash D Sharma, Steven E Pass, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 31, 2017
B-cell-targeted therapies in relapsing forms of MSDivyanshu Dubey, Thomas Forsthuber, Eoin P Flanagan, et al.Journal of Neuroimmunology|September 11, 2018
PDCB does not promote CNS autoimmunity in the context of genetic susceptibility but worsens its outcomeDivyanshu Dubey, Rehana Z Hussain, William A Miller-Little, et al.Journal of the Neurological Sciences|January 29, 2010
Knowns and unknowns in the future of multiple sclerosis treatmentOlaf StüveJournal of the Neurological Sciences|May 14, 2008
The effects of natalizumab on the innate and adaptive immune system in the central nervous systemOlaf StüveContinuum (Minneapolis, Minn.)|August 1, 2024
Autoimmune Neuromuscular Disorders Associated With Neural AntibodiesDivyanshu DubeyPageof 34